Unraveling the connection between calreticulin and myeloproliferative neoplasms via calcium signaling

• Published in: Cell biology international Vol. 47; no. 7; pp. 1229 - 1246
• Main Authors: Jaiswal, Amit, Wang, Zhiguo, Xudong, Zhu, Ju, Zhenyu
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01.07.2023
• Subjects: Calcium - metabolism; Calcium imaging; calcium ion; Calcium Signaling; Calcium signalling; Calreticulin; Calreticulin - genetics; Calreticulin - metabolism; CRIPSR‐Cas9; CRISPR; essential thrombocythemia; GROMACS; Humans; Isoforms; Molecular dynamics; molecular dynamics simulation; Mutation; Myeloproliferative Disorders - pathology; Neoplasms; Thrombocythemia, Essential - pathology; Thrombosis; essential thrombocythemia; calcium ion; calreticulin; CRIPSR-Cas9; GROMACS; molecular dynamics simulation
• ISSN: 1065-6995; 1095-8355
• DOI: 10.1002/cbin.12015

Mutations in the form of insertions and deletions (INDEL) in the calreticulin gene lead to essential thrombocythemia (ET) which is characterized by the formation of thrombosis. However, the connection between calreticulin INDEL and ET remains largely elusive. Through combined molecular dynamics simulation, clustered regularly interspaced short palindromic repeats (CRISPR) and calcium imaging studies on the wild type and mutated isoforms of calreticulin, the mechanism underlying the calreticulin INDEL induced ET was investigated at the molecular level. Our results demonstrate that mutations in exon‐9 could lead to significant conformational variations of calreticulin structure and thereby reducing its interaction with calcium ions due to decreased electrostatic contributions. The consequence of mutations on calreticulin's structural integrity was revealed by identifying the key residues and their roles in calcium binding. Furthermore, mutations implemented by CRISPR‐Cas9 in exon‐9 showed diminished calcium signaling in HEK‐293T cells, which agree well with our in‐silico findings. The current study might help in understanding the variations of molecular interactions between calreticulin's exon‐9 and calcium ions during physiological and pathological conditions. The results might also provide useful information for designing novel therapeutic approaches targeting ET.